Danapha Pharmaceutical JSC (HSTC:DAN) ROCE %: 0.00% (As of . 20)


HSTC:DAN Danapha Pharmaceutical JSC HSTC:DAN
31 GF Score
Price ₫30,300.00
! 1 Warning Sign
View Full Analysis

What is Danapha Pharmaceutical JSC ROCE %?

Danapha Pharmaceutical JSC HSTC:DAN 31 ROCE % is 0.00% as of . 20. GuruFocus rates HSTC:DAN with a GF Score™ of 31/100. The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Danapha Pharmaceutical JSC's annualized ROCE % for the quarter that ended in . 20 was 0.00%.

Danapha Pharmaceutical JSC  (HSTC:DAN) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Danapha Pharmaceutical JSC ROCE % Related Terms

Danapha Pharmaceutical JSC ROCE % Historical Data

* Premium members only.

The historical data trend for Danapha Pharmaceutical JSC's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Danapha Pharmaceutical JSC ROCE % Chart

Danapha Pharmaceutical JSC Annual Data
Trend
ROCE %

Danapha Pharmaceutical JSC Semi-Annual Data
ROCE %
HSTC:DAN
31GF Score
Danapha Pharmaceutical JSC HSTC:DAN
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Danapha Pharmaceutical JSC ROCE % Calculation

Danapha Pharmaceutical JSC's annualized ROCE % for the fiscal year that ended in . 20 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: . 20 )  (A: . 20 )(A: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( (+)/ )
=/
= %

Danapha Pharmaceutical JSC's ROCE % of for the quarter that ended in . 20 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( ( ( - ) + ( - ) )/ )
=/( ( + )/ )
=/
= %

(1) Note: The EBIT data used here is one times the annual (. 20) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 0.00% mean?
Danapha Pharmaceutical JSC (HSTC:DAN) has a ROCE % of 0.00% as of . 20.
Is Danapha Pharmaceutical JSC's ROCE % too high?
Danapha Pharmaceutical JSC's current ROCE % is 0.00%. Overall, Danapha Pharmaceutical JSC has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Danapha Pharmaceutical JSC's ROCE % compare to ZTS and UTHR?
Danapha Pharmaceutical JSC's ROCE % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 7.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 7.00, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 7.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Danapha Pharmaceutical JSC's current ROCE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Danapha Pharmaceutical JSC stock overvalued right now?
Danapha Pharmaceutical JSC (HSTC:DAN) has a current ROCE % of 0.00%. The current ROCE % is 0.00%. Danapha Pharmaceutical JSC's overall GF Score™ is 31/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Danapha Pharmaceutical JSC (HSTC:DAN), the current ROCE % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Danapha Pharmaceutical JSC Business Description

Address 253 Dung Si Thanh Khe, Da Nang, VNM
Danapha Pharmaceutical JSC is a manufacturer of herbal medicine and specific drugs such as central nervous system, neurotonics, anti-diabetics, cardiovascular drug, gastrointestinal and heaptic biliary system with forms such as tablets, capsules, injection, sirup, balm and medicated oil.
31GF Score

Get the complete analysis for HSTC:DAN

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫30,300.00
Price